IDO1 and neoplasm: The elevated serum levels and IDO1 expression in tumour correlates to clinical stage, in agreement with another study by Rose et al. showing elevated KP enzyme activity in approximately one third of early cancer patients and in half of advanced BrCa patients respectively [112].